Aplysamine-6 (78) exhibited effectiveness against isoprenylcysteine carboxyl methyltransferase (Icmt), while araplysillin-N20-formamide (112) has IC50 values of 1.1 and 3.8 μM against breast cancer cells MCF-7. Here, ICMT is linked to breast carcinoma.